Cargando…
Case Report: Long-term survival of a patient with advanced rectal cancer and multiple pelvic recurrences after seven surgeries
BACKGROUND: Rectal cancer has a high risk of recurrence and metastasis, with median survival ranging from 24 months to 36 months. K-RAS mutation is a predictor of poor prognosis in rectal cancer. Advanced rectal cancer can be stopped in its tracks by pelvic exenteration. CASE SUMMARY: A 51-year-old...
Autores principales: | Ouyang, Ye, Zhu, Yilin, Chen, Haoyi, Li, Guoquan, Hu, Xiongwei, Luo, Hongyu, Li, Zhou, Han, Shuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225707/ https://www.ncbi.nlm.nih.gov/pubmed/37256170 http://dx.doi.org/10.3389/fonc.2023.1169616 |
Ejemplares similares
-
Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)
por: Shiba, Shintaro, et al.
Publicado: (2019) -
Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node
por: Li, Shuai, et al.
Publicado: (2021) -
Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node
por: Li, Shuai, et al.
Publicado: (2021) -
Angiosarcoma of the Colon Presenting with Chronic Diarrhea, Rectal Bleeding, and Pelvic Discomfort
por: Jehangir, Asad, et al.
Publicado: (2017) -
Immune-related keratitis is a rare complication associated with nivolumab treatment in a patient with advanced colorectal cancer: A case report
por: Su, Yuqi, et al.
Publicado: (2022)